Skip to main content
. 2020 Apr 16;14:1507–1521. doi: 10.2147/DDDT.S224857

Table 4.

Safety Outcomes

Event Total (N=3170) Active Cohort (n=2679) Passive Cohort (n=491)
na IRb na IRb na IRb
Reason to consider event as serious Death 8 2.5 6 2.2 2 4.1
Life-threatening 6 1.9 6 2.2 0 0.0
Hospitalization 61 19.2 39 14.6 22 44.8
Disability/incapacityc 1 0.3 1 0.4 0 0.0
Any SAE during 28 days of follow-up 76 24.0 52 19.4 24 48.9
SAE intensity Moderate 12 3.8 9 3.4 3 6.1
Severe 52 16.4 31 11.6 21 42.8
Life-threatening 12 3.8 12 4.5 0 0
Number of persons who had SAE 62 19.6 42 15.7 20 40.7
Specific SAE during 28 days of follow-up Severe anemia 1 0.3 1 0.4 0 0
Lethargy 1 0.3 0 0 1 2.0
Severe convulsions 1 0.3 1 0.4 0 0
Severe somnolence 1 0.3 1 0.4 0 0
Severe dizziness 2 0.6 0 0 2 4.1
Spontaneous abortion 1 0.3 1 0.4 0 0
Time of event occurrenced During first 3 days 903 284.9 564 210.5 339 690.4
Between 4 and 7 days 447 141.0 377 140.7 70 142.6
After 7 days 1345 424.3 1188 443.4 157 319.8

Notes: aIndicates the number of events; a patient could have one or more events at a time. bIndicates the incidence rate per 1000 (n/N). cOne case of rheumatoid arthritis. dNumbers may not add up to total number due to missing values.

Abbreviation: SAE, serious adverse event.